Post by Gilead Sciences

837,608 followers

Innovation in the treatment landscape is critical for those living with metastatic triple-negative breast cancer (mTNBC), the most aggressive, fast-growing subtypes of breast cancer. Hear from patients and advocates on the reality behind living with mTNBC.

Post content

Video Content